ISIN: CH0461931419 | Country: Switzerland
Effective today, the shares of Vitruvia Medical AG are trading on the Munich Stock Exchange. For its listing, the company has selected Munich Stock Exchange’s general open market segment, which focuses on mid-cap financing. Vitruvia Medical AG’s initial share price stood at EUR 22.60 per share.
The state capital Munich is considered the leading technology site in Germany with a top position in Europe. Due to the close links between academic research and industry, it is a particularly attractive location for Vitruvia Medical AG.
About Vitruvia
Vitruvia Medical AG is Europe‘s foremost technology company in the healthcare sector of the circular economy, focusing on innovative circular systems for highly complex medical devices, particularly in robot-assisted surgery. Supplemented by trading, repair of medical devices as well as consulting, qualification, and other services, Vitruvia supports hospitals in the transformation of their ORs to higher value added, increased safety and maximum resource efficiency. Vitruvia is dedicated to providing innovative and sustainable solutions that deliver advances in medical technology, customer benefits and economic success.
For more information visit: www.vitruvia-med.com
Contact:
Vitruvia Medical AG
Markus A. Bertschin
Board of Directors
T +41 44 915 33 78
bertschin@vitruvia-med.com